Home › Psoriatic Arthritis › Missouri › St. Louis
Psoriatic Arthritis clinical trials in St. Louis, MO
3 studies for Psoriatic Arthritis are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- and 1 more
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
RecruitingPhase 3
- Saint Louis Rheumatology, St Louis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
- Saint Louis Children's Hospital, St Louis
About Psoriatic Arthritis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
More about Psoriatic Arthritis on MedlinePlus
Psoriatic Arthritis trials in other cities
- Houston, TX8 studies
- Charlotte, NC7 studies
- Parma, OH6 studies
- Altoona, PA6 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- Cleveland, OH5 studies
- Plantation, FL5 studies
- Clearwater, FL5 studies
- New York City, NY5 studies
- Milwaukee, WI5 studies
- San Diego, CA5 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer73 studies
- Breast Cancer64 studies
- Metastatic Cancer54 studies
- Colorectal Cancer50 studies
- Cancer (all types)46 studies
- Prostate Cancer46 studies
- Lung Cancer39 studies
- Ovarian Cancer38 studies
- Pancreatic Cancer33 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma28 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.